Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: An NRG oncology/ gynecologic oncology group study

Martee L. Hensley, Austin Miller, David M. O'Malley, Robert S. Mannel, Kian Behbakht, Jamie N. Bakkum-Gamez, Helen Michael

Research output: Contribution to journal › Article › peer-review

76 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: An NRG oncology/ gynecologic oncology group study'. Together they form a unique fingerprint.

Medicine & Life Sciences